comparemela.com

Substantial Body News Today : Breaking News, Live Updates & Top Stories | Vimarsana

BioMarin Resubmits Biologics License Application (BLA) for Valoctocogene Roxaparvovec AAV Gene Therapy for Severe Hemophilia A to the FDA

/PRNewswire/ BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) announced today that the Company resubmitted a Biologics License Application (BLA) to the U.S. Food.

United statesHank fuchsDebra charlesworthTraci mccartyEuropean commissionDrug administrationBiomarin pharmaceutical incExchange commissionWorldwide researchPrnewswire biomarin pharmaceutical incEuropean unionEuropean medicines agencyRobust clinical programSubstantial bodyPivotal phaseOngoing phase

BioMarin Resubmits Biologics License Application (BLA) for Valoctocogene Roxaparvovec AAV Gene Therapy for Severe Hemophilia A to the FDA

/PRNewswire/ BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) announced today that the Company resubmitted a Biologics License Application (BLA) to the U.S. Food.

United statesHank fuchsDebra charlesworthTraci mccartyEuropean commissionDrug administrationBiomarin pharmaceutical incExchange commissionWorldwide researchPrnewswire biomarin pharmaceutical incEuropean unionEuropean medicines agencyRobust clinical programSubstantial bodyPivotal phaseOngoing phase

vimarsana © 2020. All Rights Reserved.